Sponsor content
340 result(s) found, displaying 81 to 90
-
Australian Public Assessment Report (AusPAR)AusPAR for Vaxneuvance (pneumococcal 15-valent conjugate vaccine (CRM197 protein), adsorbed) for the prevention of pneumococcal disease.
-
Designation or determinationProvisional determination
-
Prescription medicine registrationActive ingredients: pembrolizumab.
-
Prescription medicine registrationActive ingredients: pembrolizumab.
-
Prescription medicine registrationActive ingredients: pembrolizumab.
-
Cancellation by sponsorRequested by Merck Sharp & Dohme (Australia) Pty Ltd
-
Cancellation by sponsorRequested by Merck Sharp & Dohme (Australia) Pty Ltd
-
Cancellation by sponsorRequested by Merck Sharp & Dohme (Australia) Pty Ltd
-
Cancellation by sponsorRequested by Merck Sharp & Dohme (Australia) Pty Ltd
-
Cancellation by sponsorRequested by Merck Sharp & Dohme (Australia) Pty Ltd